Biomedical Patent Securitization in Taiwan

By Mei-Hsin, Wang | Cross - Cultural Communication, September 1, 2012 | Go to article overview

Biomedical Patent Securitization in Taiwan


Mei-Hsin, Wang, Cross - Cultural Communication


Abstract

The currently funding institutes such as banks are hesitated to undertake the pledging business on intellectual property, it could be due to the lacking confidence on intellectual property or the overestimation of the high uncertainty of intellectual property, the inefficiency to cash out the pledged intellectual property assets etc.. In this article, the previous cases on intellectual property securitization worldwide were studied, in addition, the issues and suggestions for the future legislation are reviewed, and the adoption of the current finance asset securitization is discussed. My personal suggestions on securitization legislation for biomedical patent are stated and specifically explained the protection mechanism. Considering the characters of biomedical patent (such as the huge investments on equipments, long research period, complicated clinical trials and procedures, strict medicinal laws on manufactures and sales certificates approval, marketing and advertisement regulations etc.), parties involved in the securitization mechanism will not risk their qualified patents for the short term cash flow, which means lower opportunities on fraud or conspiracy comparing to the financial assets securitization. The overseas fund raising and guarantee institutes were presented. Sincerely hope this article shall contribute to the future legislation on intellectual property securitization, starting with biomedical patent securitization.

Key words: Intellectual property; Securitization; Fund raising; Asset transfer; Biomedical patent

INTRODUCTION

There are various financial arrangements for companies to convert biomedical patents into cash, such as sales from the derivative products or patents, patent licensing, joint ventures based on patent as pledges assets, strategic alliances, spinning out to form a new company, donation of patent for tax write-offs and securitization. However, the innovative financial tool on patent securitization does attract attention as shown in Figure 1, as securitization is one of the significant advancements in finance management, as a technique which revolutionized the bank as an intermediate. Securitization is also a funding mechanism. Biomedical technologies advanced human life and the innovations did generate benefits towards the better quality of human life. As an updated financial tool, intellectual property backed asset securitization will enhance the development of technologies. Intellectual property backed asset securitization is a newer type of asset backed securitization, providing borrowers with cheaper sources of funds. Furthermore, borrowers, originators, investors will benefit from the advantages of this structured financial tool, since intellectual property backed asset securitization leads to a more efficient financial market and reduce costs of intermediation for both loan originators and borrows.

There are many concerns for the securitization implemented for intellectual properties, such as the statutory and legal mechanisms which presently do not exist in Taiwan, however, the asset-backed securitization on real estate and financial derivative products are already launched in Taiwan. For biomedical patents, securitization is a newer funding source and the biomedical patents have more profound foundations while comparing to patents in other industries. Regarding the foundations for biomedical patents, at least, a physically existed biomedical company with factory or laboratory is a must, and the biomedical technologies somehow build up higher competitive barriers as technologies development is a time consuming with huge capital demanding business.

Although there already are existed various innovative financial derivative products and flexible financial measures for intellectual properties, intellectual property backed asset securitization offers unique benefits, such as funding with lower cost for individual patent owner or company assignees, which is a trendy fashion for capital management. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Biomedical Patent Securitization in Taiwan
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Author Advanced search

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.